2007 survey of medical toxicology practice improvement activities

Suzanne R White1, Beth Baker, Carl R Baum

  • 1American Board of Emergency Medicine, East Lansing, MI, USA. swhite1@dmc.org

Insights

Medical Toxicologists (MTs) show varied engagement in practice improvement (PI) activities. Many MTs find proposed practice performance assessments intrusive, highlighting barriers to implementing PI programs.

Area of Science:

  • Medical Toxicology
  • Healthcare Quality Improvement
  • Professional Development

Background:

  • No prior studies assessed Medical Toxicologists' (MTs) practice improvement (PI) activities.
  • The MT Assessment of Practice Performance (APP) Taskforce initiated this study to understand current PI practices and perceptions.

Purpose of the Study:

  • To assess current PI activities available in MT practice settings.
  • To identify potential APP activities aligning with MT practice.
  • To explore the relationship between MT practice patterns and APP requirements.

Main Methods:

  • A survey was distributed to MT diplomates.
  • 127 surveys were completed, querying about available PI activities, suitable APP activities, and APP requirements.
  • Data on participation, data collection, and perceived validity of PI measures were collected.

Main Results:

  • Approximately one-third of MTs are not involved in PI activities.
  • Few collected performance improvement data, mostly through CME, case, or chart reviews.
  • Peer reviews and self-improvement plans were deemed most valid PI measures; most APP options were perceived as intrusive.

Conclusions:

  • Participation in MT PI activities is not universal, with significant barriers perceived.
  • Hospitals and poison centers are optimal settings for APP administration.
  • Understanding MTs' opinions is crucial for developing effective APP programs.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...